logo
Sign in

EMULATE, INC.

BOSTON, MA · Founded 2013 · Medtech · Private

Microphysiological systems (organ-on-chip devices) that model human liver disease using primary hepatic cells in microengineered environments

Claim this profile

Follows are private to you and power your alerts

Updated · emulate.com

Sector
Medtech
Headquarters
BOSTON, MA
Founded
2013
Latest Form D
$57.5M, Sep 2021
Total capital
$182M
Federal grants
$150K
1 award · 2018
Rank in peer group#6 of 1112
Private capital raised
$182M
7 Form D · last Sep 2021
62 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
28
12 pending · first 2022
Rank in peer group#23 of 1112

Capital timeline

20142015201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $182M$150K1st Form D$12M2nd Form D$28.8M7th Form D$57.5M
2014201620182020FEDERAL ↑EQUITY ↓Cumulative $182M$150K

Latest events

  • Private capital raisedForm D · SEC · 7th filing$57.5M
  • Private capital raisedForm D · SEC · 6th filing$19.3M
  • Private capital raisedForm D · SEC · 5th filing$28M
  • Private capital raisedForm D · SEC · 4th filing$36M
  • Federal grantHealth and Human S · Phase I · Development of a Human Liver Microphysiological System For Alcoholic Liver Disease$150K
  • Private capital raisedForm D · SEC · 3rd filing$746K
  • Private capital raisedForm D · SEC · 2nd filing$28.8M
  • Private capital raisedForm D · SEC · 1st filing$12M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Federal grants#6 · top 1%
  • Granted patents#23 · top 2%
  • Linked publications#3 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Daniel R. LevnerResearcherExecutive Officer, DirectorLinked by 2 patents
  • Aaron A. VanDevenderDirectorNamed in SEC Form D filings
  • Andrew D. StevensonDirectorNamed in SEC Form D filings
  • David James CoonExecutive Officer, DirectorNamed in SEC Form D filings
  • Donald IngberDirectorNamed in SEC Form D filings
  • Eric D. MoessingerDirectorNamed in SEC Form D filings
Show all 22 people
  • Franklin WitneyDirectorNamed in SEC Form D filings
  • Geraldine HamiltonExecutive Officer, DirectorNamed in SEC Form D filings
  • Gregory D. WilliamsExecutive OfficerNamed in SEC Form D filings
  • Hansjoerg D. WyssDirectorNamed in SEC Form D filings
  • Harminder R. DhaliwalExecutive OfficerNamed in SEC Form D filings
  • James David CoonExecutive Officer, DirectorNamed in SEC Form D filings
  • James CorbettExecutive OfficerNamed in SEC Form D filings
  • Larry WeissExecutive OfficerNamed in SEC Form D filings
  • Lewis D. RoweExecutive OfficerNamed in SEC Form D filings
  • Martin MadausDirectorNamed in SEC Form D filings
  • Michael EgholmDirectorNamed in SEC Form D filings
  • Monique NoelExecutive OfficerNamed in SEC Form D filings
  • Sandy R. LazzariExecutive OfficerNamed in SEC Form D filings
  • Scott KantorExecutive OfficerNamed in SEC Form D filings
  • Sharon R. KedarDirectorNamed in SEC Form D filings
  • Shlomo MelmedDirectorNamed in SEC Form D filings

What it has protected

USPTO · 28 granted of 40
Show all 40 patent records

Recent research by its founders

  • Potent Liver‐Tropic mRNA Lipid Nanoparticles: ApoE‐Mediated Delivery Through a Low‐Density Lipoprotein Receptor Independent Uptake Mechanism (Adv. Mater. 22/2026)20260 cites
  • Potent Liver‐Tropic mRNA Lipid Nanoparticles: ApoE‐Mediated Delivery Through a Low‐Density Lipoprotein Receptor Independent Uptake Mechanism20252 cites
  • Modeling alcohol-associated liver disease in a human Liver-Chip202182 cites

Related companies, and why

  • Tector, Inc.Similar federal contract value in Medtech · null in contracts
  • DeVoro Medical Inc.Similar federal contract value in Medtech · null in contracts
  • Naveris, Inc.Similar federal contract value in Medtech · null in contracts
  • REDIMINDS INCSimilar federal contract value in Medtech · null in contracts
  • Sharklet Technologies Inc.Similar federal contract value in Medtech · null in contracts
  • Marblehead Medical LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .